Checkmate Capital
Overview
Checkmate Capital is an advisory and investment group that specializes in biotechnology, energy technology, and agriculture technology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Lactiga | Sep 2022 | Pre Seed | Co-investor |
| Lynx Biosciences | Nov 2021 | Seed | Lead |
| Precision Livestock Technologies | Sep 2022 | Accelerator | Lead |
| NeuroSigma | Dec 2025 | Corporate Funding | Lead |
| Austrianova | Mar 2023 | VC Round | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Checkmate Capital based?
Checkmate Capital is headquartered in Pasadena, California, United States.
When was Checkmate Capital founded?
Checkmate Capital was founded in 2017.
How many portfolio companies does Checkmate Capital have?
Checkmate Capital has 8 portfolio companies in Caplight's dataset.
What are some companies in Checkmate Capital's portfolio?
Portfolio companies visible on Caplight include Lactiga, Lynx Biosciences, Precision Livestock Technologies, NeuroSigma, Austrianova.
What was Checkmate Capital's most recent investment shown here?
Checkmate Capital's most recent investment in this portfolio sample was in NeuroSigma in 2025.
What sectors does Checkmate Capital focus on?
Checkmate Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Checkmate Capital focus on?
Checkmate Capital typically invests at the Early stage.
What is Checkmate Capital's AUM?
Checkmate Capital's assets under management are estimated between $0.0 and $50.0M.